Lyra Therapeutics Inc
LYRA6.726USD
+0.146+2.21%
交易中 （美東）報價延遲15分鐘
8.86M總市值
虧損本益比TTM
關於 Lyra Therapeutics Inc 公司
Lyra Therapeutics, Inc. 是一家臨牀階段的生物技術公司。該公司專注於開發和商業化用於局部治療慢性鼻竇炎 (CRS) 患者的療法。該公司有兩種研究性候選產品 LYR-210 和 LYR-220，正處於針對 CRS 的後期開發階段，CRS 是一種常見的鼻旁竇炎症性疾病，會導致衰弱症狀和嚴重發病率。LYR-210 和 LYR-220 是生物可吸收的鼻植入物，旨在通過簡單的診室手術進行給藥，旨在爲鼻腔通道提供六個月的持續糠酸莫米松藥物治療。 LYR-210 專爲未接受過手術的患者設計，目前正在 ENLIGHTEN 第三期臨牀項目中進行評估，而 LYR-220 正在 BEACON 第二期臨牀試驗中進行評估，針對的是儘管曾接受過篩竇手術但仍有復發症狀的患者。
公司簡介
公司代碼LYRA
公司名稱Lyra Therapeutics Inc
上市日期May 01, 2020
CEODr. Maria Palasis, Ph.D.
員工數量30
證券類型Ordinary Share
年結日May 01
公司地址480 Arsenal Way
城市WATERTOWN
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編02472
電話16173734600
網址https://lyratherapeutics.com/
公司代碼LYRA
上市日期May 01, 2020
CEODr. Maria Palasis, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Harlan W. Waksal, M.D.
Dr. Harlan W. Waksal, M.D.
Executive Chair and Chairperson of the Board
Executive Chair and Chairperson of the Board
10.74K
--
Dr. Nancy L. Snyderman, M.D.
Dr. Nancy L. Snyderman, M.D.
Independent Director
Independent Director
--
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Dr. Richard Nieman, M.D.
Dr. Richard Nieman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. James R (Jim) Tobin
Mr. James R (Jim) Tobin
Lead Independent Director
Lead Independent Director
--
--
Ms. C. Ann Merrifield
Ms. C. Ann Merrifield
Independent Director
Independent Director
--
--
Mr. W. Bradford Smith
Mr. W. Bradford Smith
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Harlan W. Waksal, M.D.
Dr. Harlan W. Waksal, M.D.
Executive Chair and Chairperson of the Board
Executive Chair and Chairperson of the Board
10.74K
--
Dr. Nancy L. Snyderman, M.D.
Dr. Nancy L. Snyderman, M.D.
Independent Director
Independent Director
--
--
Dr. Maria Palasis, Ph.D.
Dr. Maria Palasis, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
-100.00%
Dr. Richard Nieman, M.D.
Dr. Richard Nieman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. James R (Jim) Tobin
Mr. James R (Jim) Tobin
Lead Independent Director
Lead Independent Director
--
--
Ms. C. Ann Merrifield
Ms. C. Ann Merrifield
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月27日 週日
更新時間: 7月27日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Perceptive Advisors LLC
15.96%
North Bridge Venture Partners
7.37%
BlackRock Institutional Trust Company, N.A.
3.76%
The Vanguard Group, Inc.
2.21%
Samsara BioCapital, LLC
1.74%
Other
68.96%
持股股東
持股股東
佔比
Perceptive Advisors LLC
15.96%
North Bridge Venture Partners
7.37%
BlackRock Institutional Trust Company, N.A.
3.76%
The Vanguard Group, Inc.
2.21%
Samsara BioCapital, LLC
1.74%
Other
68.96%
股東類型
持股股東
佔比
Private Equity
15.96%
Venture Capital
9.11%
Investment Advisor
7.83%
Hedge Fund
3.54%
Investment Advisor/Hedge Fund
2.87%
Research Firm
0.73%
Individual Investor
0.69%
Pension Fund
0.20%
Bank and Trust
0.06%
Other
59.00%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
168
655.29K
41.00%
-531.79K
2025Q1
169
680.57K
41.01%
-508.15K
2024Q4
169
34.27M
52.36%
-23.86M
2024Q3
170
41.74M
67.36%
-17.33M
2024Q2
155
41.35M
70.46%
-15.27M
2024Q1
137
54.47M
94.92%
+4.29M
2023Q4
113
50.90M
93.69%
+8.93M
2023Q3
96
40.42M
84.31%
-314.10K
2023Q2
103
42.33M
88.17%
+11.26M
2023Q1
124
25.98M
81.63%
-890.12K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Perceptive Advisors LLC
255.15K
15.96%
--
--
Mar 31, 2025
North Bridge Venture Partners
117.77K
7.37%
--
--
Mar 18, 2025
BlackRock Institutional Trust Company, N.A.
60.03K
3.76%
-1.59K
-2.59%
Mar 31, 2025
The Vanguard Group, Inc.
35.31K
2.21%
-436.00
-1.22%
Mar 31, 2025
Samsara BioCapital, LLC
27.80K
1.74%
-11.51K
-29.28%
Mar 31, 2025
Ikarian Capital LLC
21.16K
1.32%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
20.32K
1.27%
+2.60K
+14.68%
Mar 31, 2025
Nantahala Capital Management, LLC
12.56K
0.79%
+12.56K
--
Sep 30, 2024
Two Sigma Investments, LP
11.15K
0.7%
-758.00
-6.36%
Mar 31, 2025
Waksal (Harlan W)
10.74K
0.67%
--
--
Mar 18, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
ProShares Hedge Replication ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
0%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Growth ETF
0%
查看更多
ProShares Hedge Replication ETF
佔比0%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Micro-Cap ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Proshares Ultra Russell 2000
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
